Final results of local-regional control and late toxicity of rtog 9003: A randomized trial of altered fractionation radiation for locally advanced head and neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 1, 2014, Pages 13-20

  Beitler, Jonathan J ^a   Zhang, Qiang ^b   Fu, Karen K ^c   Trotti, Andy ^d   Spencer, Sharon A ^e   Jones, Christopher U ^f   Garden, Adam S ^g   Shenouda, George ^h   Harris, Jonathan ^b   Ang, Kian K ^g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Radiological Associ of Sacramento   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; TOXICITY; TUBES (COMPONENTS);

CONFIDENCE INTERVAL; HYPERFRACTIONATION; LATE TOXICITIES; LOCALLY ADVANCED HEAD AND NECK CANCERS; METHODS AND MATERIALS; OVERALL SURVIVAL; RANDOMIZED TRIAL; TWICE-DAILY FRACTIONS;

PATIENT TREATMENT;

ACUTE TOXICITY; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEEDING APPARATUS; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; REGIONAL PERFUSION; RISK ASSESSMENT; SECOND CANCER; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; CONFIDENCE INTERVALS; DOSE FRACTIONATION; ENTERAL NUTRITION; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; RADIATION INJURIES; TIME FACTORS; TONGUE NEOPLASMS; TREATMENT FAILURE;

EID: 84898854161     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.12.027     Document Type: Article

References (28)

1. K.K. Fu, T.F. Pajak, and A. Trotti et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16 (Pubitemid 30488207)
2. H. Coutard Principles of x ray therapy of malignant diseases Lancet 2 1934 1 8
3. J.C. Horiot, R. Le Fur, and T. N'Guyen et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231 241 (Pubitemid 23000765)
4. K.K. Fu, T.F. Pajak, and V.A. Marcial et al. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG-83-13 Int J Radiat Oncol Biol Phys 32 1995 577 588
5. J.T. Parsons, W.M. Mendenhall, and S.P. Stringer et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience Head Neck 15 1993 87 96 (Pubitemid 23066885)
6. C.C. Wang, P.H. Blitzer, and H.D. Suit Twice-a-day radiation therapy for cancer of the head and neck Cancer 55 1985 2100 2104 (Pubitemid 15119173)
7. K.K. Ang, L.J. Peters, and R.S. Weber et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx Int J Radiat Oncol Biol Phys 19 1990 1339 1345
8. J. Dutreix, M. Tubiana, and A. Wambersie et al. The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy Eur J Cancer 7 1971 205 213
9. L.J. Peters, K.K. Ang, and H.D. Thames Jr. Accelerated fractionation in the radiation treatment of head and neck cancer: A critical comparison of different strategies Acta Oncol 27 1988 185 194
10. L.M. Brown, P. McCarron, and D.M. Freedman Buccal cavity and pharynx R.E. Curtis, D.M. Freedman, E. Ron, New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006 National Cancer Institute Bethesda, MD
11. D.R. Cox Regression models and life-tables J R Stat Soc Series B Stat Methodol 1972 187 220
12. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
13. R.J. Gray A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 1988 1141 1154
14. J. Kalbfleisch, and R. Prentice The statistical analysis of failure time data The Statistical Analysis of Failure Time Data 1980 Wiley New York
15. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
16. J. Bourhis, J. Overgaard, and H. Audry et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis Lancet 368 2006 843 854 (Pubitemid 44292807)
17. R. Semrau, R.P. Mueller, and H. Stuetzer et al. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: Updated results of a randomized multicentric trial in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 64 2006 1308 1316
18. S. Staar, V. Rudat, and H. Stuetzer et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: Results of a multicentric randomized German trial in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 1161 1171 (Pubitemid 32727792)
19. J. Bourhis, C. Sire, and P. Graff et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): An open-label phase 3 randomised trial Lancet Oncol 13 2012 145 153
20. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
21. P. Nguyen-Tan, E. Zhang, and R.H. Wheeler et al. A phase 3 trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): Long-term report of efficacy and toxicity Int J Radiat Oncol Biol Phys 87 2013 S56 S57
22. J. Overgaard, H.S. Hansen, and L. Specht et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 2003 933 940 (Pubitemid 37159288)
23. J. Overgaard, B.K. Mohanti, and N. Begum et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): A randomised, multicentre trial Lancet Oncol 11 2010 553 560
24. A.A. Forastiere, Q. Zhang, and R.S. Weber et al. Long-term results of RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer J Clin Oncol 31 2013 845 852
25. J.S. Cooper, Q. Zhang, and T.F. Pajak et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: Postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck Int J Radiat Oncol Biol Phys 84 2012 1198 1205
26. J. Bernier, J.S. Cooper, and T.F. Pajak et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501) Head Neck 27 2005 843 850 (Pubitemid 41395696)
27. J.J. Beitler, and J.S. Cooper Seduction by induction? J Clin Oncol 27 2009 9 10
28. S.M. Bentzen, B.M. Atasoy, and F.M. Daley et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial J Clin Oncol 23 2005 5560 5567